This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

PROMETHERA BIOSCIENCES

Thank you for visiting our virtual exhibit

PROMETHERA BIOSCIENCES S.A./N.V.


COMPANY BACKGROUND

Promethera® Biosciences is a global innovator in liver therapeutics whose mission is to bring patients life-saving treatments to reduce the need for liver transplantation. The Company has developed its cell therapy technologies by using allogeneic stem and progenitor liver cells. Promethera®’s lead clinical program, derived from its patented cell technology platform HepaStem™, is designed to benefit from its immune-modulatory and anti-fibrotic properties. The Company has strengthened its development portfolio by developing antibody technologies, such as the anti-TNF-R1 antibody Atrosimab to complement its therapeutics options. Promethera®’s team is composed of international experts operating in Belgium, USA, Japan & Switzerland.


ADDED VALUE
•A worldwide company with a local presence in 4 countries.
•A unique set of technological assets to bring life-saving treatments to reduce the need for liver transplantation.
•Largest liver sourcing and unique supply chain on a global basis.
•Robust investor consortium.


RANGE OF PRODUCTS

Cell Therapies:
•HepaStem™ for ACLF (IM) in Phase 2B
•HepaStem™ for NASH/Fibrosis starting Phase 2A
•H2Stem® for Tissue Repair in Pre-Clinical phase
Biologicals:
•Atrosimab for NASH/Fibrosis in Pre-Clinical Phase 

 

CONTACT INFO 

Watson & Crick Hill
Rue Granbonpré, 11
1435 MONT-SAINT-GUIBERT
Tel : +32 10 39 43 00
E-mail : info@promethera.com
Website : www.promethera.com 

 
DELEGATE

Luc OTTEN, Chief Scientific Officer
Mobile : +32 478 78 10 47
E-mail : luc.otten@promethera.com
Victoria BETOESKI, Global Associate Director Strategic Planning & Corporate Development
Mobile : +32 470 98 08 99
E-mail : victoria.betoeski@promethera.com